Show simple item record

dc.contributor.authorBayman, Neil A
dc.contributor.authorAlam, Nooreen
dc.contributor.authorFaivre-Finn, Corinne
dc.date.accessioned2010-03-15T16:41:17Z
dc.date.available2010-03-15T16:41:17Z
dc.date.issued2010-01-14
dc.identifier.citationRadiotherapy for lung cancer in the elderly. 2010: Lung Canceren
dc.identifier.issn1872-8332
dc.identifier.pmid20079949
dc.identifier.doi10.1016/j.lungcan.2009.12.004
dc.identifier.urihttp://hdl.handle.net/10541/94251
dc.description.abstractMortality from lung cancer is increasing in patients>/=70 years. Radiotherapy has an important role in the treatment of lung cancer for this group. Despite this, there have been few elderly specific trials of radiotherapy in lung cancer and current treatment is often based on evidence extrapolated from studies treating younger patients. This review of the literature examines the impact of radiotherapy for the radical and palliative treatment of non-small-cell and small-cell lung cancer, on survival, treatment-related toxicity and quality of life in the elderly. We also comment on the need for validated, practical geriatric screening and assessment tools to help predict toxicity to treatment.
dc.languageENG
dc.language.isoenen
dc.subjectLung Canceren
dc.subjectRadiotherapyen
dc.subjectAgeden
dc.titleRadiotherapy for lung cancer in the elderly.en
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Oncology, The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester, M20 4BX, United Kingdom.en
dc.identifier.journalLung Canceren
html.description.abstractMortality from lung cancer is increasing in patients>/=70 years. Radiotherapy has an important role in the treatment of lung cancer for this group. Despite this, there have been few elderly specific trials of radiotherapy in lung cancer and current treatment is often based on evidence extrapolated from studies treating younger patients. This review of the literature examines the impact of radiotherapy for the radical and palliative treatment of non-small-cell and small-cell lung cancer, on survival, treatment-related toxicity and quality of life in the elderly. We also comment on the need for validated, practical geriatric screening and assessment tools to help predict toxicity to treatment.


Files in this item

This item appears in the following Collection(s)

Show simple item record